Jinluan Chen

Rotterdam, ZH 3015GD, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Skin Advanced Glycation End Products (AGEs) are not associated with bone mineral density longitudinally: The Rotterdam Study.

Skin Advanced Glycation End Products (AGEs) are not associated with bone mineral density longitudinally: The Rotterdam Study.

Journal: Bone

Published: May 20, 2025

Integrating Gut Microbiome and Metabolome to Gain Insight into Metabolic Dysfunction-Associated Steatotic Liver Disease.

Integrating Gut Microbiome and Metabolome to Gain Insight into Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gastro hep advances

Published: February 27, 2025

Metabolomic profiles in serum uncover novel biomarkers in children with Williams-Beuren syndrome.

Metabolomic profiles in serum uncover novel biomarkers in children with Williams-Beuren syndrome.

Journal: Scientific reports

Published: October 21, 2024

The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.

The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.

Journal: Respiratory research

Published: September 04, 2023

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study.

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study.

Journal: Cardiovascular diabetology

Published: August 25, 2023

Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study.

Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study.

Journal: Nutrients

Published: March 31, 2023

Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort.

Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort.

Journal: Scientific reports

Published: October 21, 2022

Dietary advanced glycation end-products (dAGEs) intake and its relation to sarcopenia and frailty - The Rotterdam Study.

Dietary advanced glycation end-products (dAGEs) intake and its relation to sarcopenia and frailty - The Rotterdam Study.

Journal: Bone

Published: April 01, 2022

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.

Journal: Diabetologia

Published: December 09, 2021

Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study.

Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: November 04, 2021

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 02, 2021

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.

Journal: JAMA network open

Published: January 08, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026